Paper Applicator Acceptability Study
NCT02179138
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Study no longer relevant based on change in regulatory pathway for TFV 1% gel
Conditions
HIV Prevention
Interventions
DRUG:
TFV 1% gel
Sponsor
CONRAD